Features
Colazide® is indicated for the treatment of mild-to-moderate active ulcerative colitis and maintenance of remission, in patients who are intolerant to sulfasalazine.
Colazide® is indicated for the treatment of mild-to-moderate active ulcerative colitis and maintenance of remission, in patients who are intolerant to sulfasalazine.